Translational Research Institute
March 24, 2017
UAMS Visitor Talks Latino Health Paradox and Cinco de Mayo
March 24, 2017 | A couple of common misconceptions about Hispanics were highlighted in talks by David E. Hayes-Bautista, Ph.D., who visited UAMS and the Clinton School of Public Service last week. Hayes-Bautista, a distinguished professor of medicine from the University of California, Los Angeles, noted that Latinos are often incorrectly lumped with other minorities…
July 5, 2016
NIH Awards Early Career Grants to Two UAMS Translational Research Institute–Trained Researchers
July 5, 2016 | University of Arkansas for Medical Sciences (UAMS) early career researchers Joshua Kennedy, M.D., and Taren Swindle, Ph.D., are recipients of National Institutes of Health (NIH) grants that will support their work over the next several years. In May, Kennedy, whose laboratory is at Arkansas Children’s Hospital Research Institute (ACHRI) on the Arkansas…
April 19, 2016
New UAMS Website Helps Arkansans Volunteer for Research
April 19, 2016 | Arkansans are now able to volunteer for research studies through a new website developed by the University of Arkansas for Medical Sciences (UAMS) Translational Research Institute. Called ARresearch.org, the website announced today gives Arkansans a place to sign up if they want to be contacted about UAMS studies that are enrolling…
November 6, 2015
UAMS Staff Expertise Helps Researcher Make History
Nov. 6, 2015 | Behind the headlines of his breast cancer vaccine, now in a phase II clinical trial, UAMS’ Thomas Kieber-Emmons, Ph.D., tells a back story that inspires him and even draws applause from colleagues. Kieber-Emmons peppers the story with some significant numbers: 1, 6, 28, 1,500, 4,000. The story begins in 2005 with…
January 29, 2015
UAMS Startup Gets $14.5 Million to Develop Drug Therapies for Methamphetamine Users
January 29, 2015 | A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.
Previous page